Investors often follow stocks that gain momentum, and for good reason. These stocks tend to maintain their direction for a while, presenting opportunities for quick gains.
In this feature, we’ll take a look at four OTC stocks carrying some trading momentum.
ResGreen Group International Inc. (OTC:RGGI) is at the intersection of Industry 4.0 and the human-focused principles of Industry 5.0. RGGI seeks to revolutionize the world of manufacturing with leading-edge artificial intelligence and mobile robots. The overarching aim of the company is to provide small and medium-scale industries with cutting-edge technologies, helping to close the gap with the behemoths of the industry.
RGGI is known for its holistic approach, which integrates artificial intelligence-powered workplace optimization, multi-platform communication, collaborative human-robot interfaces, and unreal engine simulations. ResGren Group essentially allows companies to compete with bigger rivals by enhancing productivity, reducing costs, and promoting data-driven decisions.
On August 31, RGGI announced that it hit a major milestone after it managed to successfully optimize its manufacturing and warehousing operations with the object detection algorithm You Only Look Once (YOLO). This algorithm can help with the detection of vacant storage areas or low-stock areas in warehouse facilities, thereby optimizing efficiency and streamlining business processes.
“Embracing the leading-edge YOLO object detection technology underscores our growing commitment to harnessing the power of AI-driven solutions,” said Parsh Patel, CEO at ResGreen. “YOLO’s renowned real-time, single-pass object recognition framework lays the foundation for predictive analytics, dynamic resource allocation, and continuous operational improvement, putting us at the forefront of intelligent manufacturing and warehouse management.”
On August 29, RGGI unveiled its path-breaking simulation program, SimuPath. The program is aimed at enhancing productivity and performance in warehouses and manufacturing facilities. The press release also revealed that the program deployed Unreal Engine, a 3D creation tool, for the purpose of designing the perfect virtual version of a warehouse or manufacturing facility.
“By leveraging AI, robotics, and high-powered game engine simulations, we are creating a future-ready solution for our customers that not only significantly improves their current operations but also offers a new vision of how effective and efficient their assembly, delivery, and picking processes can be,” said Parsh Patel, ResGreen CEO.
The artificial intelligence in SimuPath helps with the determination of the best routes, which would lead to optimum efficiency for material handling. In turn, the program also relays the information to BigBuddy, the cutting-edge line of mobile robots that belongs to ResGreen Group International.
Another significant announcement from the company came on August 22, when it announced the launch of its artificial intelligence-powered chatbot. ResGreen Group launched the chatbot to make its communications with its investors more streamlined and efficient. It had been developed in-house and would be necessary for providing fast answers to the company’s investors.
CEO Patel noted that the company was deploying modern technology not only in its product offerings but also in the tools through which it communicated with its investors. He went on to note that the chatbot would provide answers to queries around the clock and would also deliver answers in multiple languages so as to serve the company’s diverse investor base.
ResGreen Group International Inc. (OTC: RGGI) is making significant strides in the realm of advanced technologies. Their adoption of AI-driven workplace optimization, mobile robots, and an AI-powered chatbot for investor communication showcases their commitment to innovation. RGGI’s focus on cutting-edge solutions makes it an intriguing option for those seeking potential penny stock opportunities for their watchlist
Digital Locations Inc. (OTC: DLOC) is a disruptive technology developer that is involved in providing high-speed internet straight to smartphones all over the world through satellites. Given that high-speed internet, also known as broadband internet, is only available in densely populated areas, the service offered by Digital Locations Inc. is particularly important.
On September 12, the company announced that it had entered into an equity financing agreement with GHS Investments LLC. As per the provisions of the agreement, GHS would pick up $10 million worth of the registered common stock of the company. Digital Locations would determine the amounts to be bought and the timing of those purchases. The company intends to develop its innovative technology for providing high-speed internet to smart phones globally by using the proceeds from the new capital.
“This financing from GHS will help accelerate the development of our disruptive technology,” said Rich Berliner, CEO of Digital Locations. “We appreciate the confidence that GHS has placed in us.”
GHS is a privately held management and investment group. It is mainly involved in providing financing backing to small-cap companies that possess considerable potential.
On September 12, the company also filed an 8K with the United States Securities and Exchange Commission. Investors who may be interested in the specific terms and conditions of the investment from GHS could consider going through the filing for more information.
Northwest Biotherapeutics (OTC:NWBO) is a biotech firm that is involved in the development of customized immunotherapy products that aim to treat different forms of cancer more effectively than prevalent treatments. The treatments offered by Northwest Biotherapeutics do not cause toxic reactions, which are generally associated with chemotherapies. Additionally, it also offers its products at a competitive price in both the European and North American markets. The company is currently best known for its work on the development of DCVax, which are personalized immune therapies meant for treating solid tumors related to cancer.
On September 12, the company announced that there had been a new addition to its Scientific Advisory Board (SAB) following the joining of Dr. Linda Liau, MD, PHD, and MBA. In the news release, the company noted that Dr. Liau had also served as the lead investigator at the Phase 3 trial of DCVax-L.
Currently, Dr. Liau is the Chair of the Department of Neurosurgery at UCLA and Professor and Director of the Brain Tumor Program at UCLA. She is also the Director of the UCLA Brain Cancer SPORE (Specialized Program of Research Excellence) and the Editor in Chief of the Journal of Neuro-Oncology. She had also been elected a member of the National Academy of Medicine.
The Chief Executive Officer of the company, Linda Powers, noted that everyone at the company was delighted that Dr. Liau joined the distinguished SAB at Northwest Biotherapeutics. Powers went on to state that Dr. Liau had decades of knowledge and research experience in not only immunotherapies but also in brain cancer biology. Her experience with the principal investigator in the Phase 3 trial of DCVax-L would also prove to be a priceless attribute as the company continued to work towards the approval of the product.
HUMBL Inc. (OTC:HMBL) is best known for operating a technology platform that offers a wide range of product lines. Some of the products from HUMBL Inc. include HUMBL Wallet, HUMBL Authentics, HUMBL Tickets, HUMBL Marketplace, HUMBL Search Engine, and HUMBL Social.
On August 31, the company announced that it had made a strategic expansion of its relationship with Pacific Lion, its funding partner. In the news release, the company announced that the expansion was an indication of Pacific Lion’s commitment to the continued growth of HUMBL. Pacific Lion raised its funding commitment to HUMBL in order to strengthen the company’s financial situation and ensure the availability of significant working capital ahead of the Reg A offering. In order to provide the extra funding, Pacific Lion amended its existing note with the company and boosted the potential funding amount to $2,000,000. Previously, the note bore a potential funding amount of a maximum of $800,000.
Additionally, in a further demonstration of confidence in HUMBL’s business prospects, it was announced that the Pacific Lion warrant would be terminated in an 18-month period if the company failed to be uplisted on a major exchange during that interval. In effect, the condition reveals Pacific Lion’s confidence about the efforts that had been put in by HUMBL towards the uplisting. The Managing Director of Pacific Lion, Jacob Fernane, spoke about the relationship as well.
He stated that Pacific Lion was privileged to have served as the major financial partner of HUMBL at a key juncture in the history of the company. He went on to add that the strong executive leadership at HUMBL was also in alignment with Pacific Lion’s own vision for the company. He stated that Pacific Lion was resolute in supporting the capital requirements of HUMBL.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Cambridge Consulting to assist in the production and distribution of content related to RGGI. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.